Ocuphire Pharma is a late clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of retinal and refractive eye disorders.
Targets: Pharmacologically-induced Mydriasis, Presbyopia, and Dim Light or Night Vision Disturbances
Phentolamine Ophthalmic Solution 0.75% Eye Drops is a once-daily preservative-free eye drop formulation designed to reduce pupil size and improve visual acuity.
